Integra LifeSciences (IART) Competitors

Integra LifeSciences (NASDAQ:IART) and Integer (NYSE:ITGR) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, analyst recommendations, institutional ownership, valuation, media sentiment, risk and profitability.

Which has more risk and volatility, IART or ITGR?

Integra LifeSciences has a beta of 1.16, suggesting that its share price is 16% more volatile than the S&P 500. Comparatively, Integer has a beta of 1.02, suggesting that its share price is 2% more volatile than the S&P 500.

Do institutionals & insiders believe in IART or ITGR?

84.8% of Integra LifeSciences shares are owned by institutional investors. Comparatively, 99.3% of Integer shares are owned by institutional investors. 3.5% of Integra LifeSciences shares are owned by company insiders. Comparatively, 2.2% of Integer shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Is IART or ITGR more profitable?

Integer has a net margin of 4.61% compared to Integra LifeSciences' net margin of -30.87%. Integer's return on equity of 12.27% beat Integra LifeSciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Integra LifeSciences	-30.87%	12.15%	4.32%
Integer	4.61%	12.27%	6.23%

Do analysts recommend IART or ITGR?

Integra LifeSciences currently has a consensus price target of $18.63, indicating a potential upside of 36.75%. Integer has a consensus price target of $140.25, indicating a potential upside of 31.37%. Given Integra LifeSciences' higher possible upside, research analysts plainly believe Integra LifeSciences is more favorable than Integer.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Integra LifeSciences	4 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	1.78
Integer	0 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	3.00

Does the media prefer IART or ITGR?

In the previous week, Integer had 5 more articles in the media than Integra LifeSciences. MarketBeat recorded 11 mentions for Integer and 6 mentions for Integra LifeSciences. Integer's average media sentiment score of 1.21 beat Integra LifeSciences' score of 0.69 indicating that Integer is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Integra LifeSciences	1 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Integer	8 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has higher earnings and valuation, IART or ITGR?

Integer has higher revenue and earnings than Integra LifeSciences. Integra LifeSciences is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Integra LifeSciences	$1.61B	0.66	-$6.94M	-$6.53	-2.09
Integer	$1.72B	2.18	$119.90M	$2.27	47.03

Summary

Integer beats Integra LifeSciences on 14 of the 17 factors compared between the two stocks.